Maibritt Norgaard
Palle Juul Jensens Boulevard 99
Aarhus N, 8200, Denmark
Aarhus N, 8200, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Genome-wide methylome profiling of cell-free DNA enables prognostication of patients with castration-resistant prostate cancer.
Journal: British journal of cancer
Published: October 07, 2025
Deep targeted sequencing of circulating tumor DNA to inform treatment in patients with metastatic castration-resistant prostate cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: October 14, 2024
Exploring the tumor genomic landscape of aggressive prostate cancer by whole-genome sequencing of tissue or liquid biopsies.
Journal: International journal of cancer
Published: August 15, 2023
Prognostic Value of Low-Pass Whole Genome Sequencing of Circulating Tumor DNA in Metastatic Castration-Resistant Prostate Cancer.
Journal: Clinical chemistry
Published: August 25, 2022
Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factors.
Journal: The Journal of pathology
Published: February 15, 2021
Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential.
Journal: Cells
Published: May 01, 2020
Epigenetic silencing of MEIS2 in prostate cancer recurrence.
Journal: Clinical epigenetics
Published: February 06, 2019
Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer.
Journal: International journal of molecular sciences
Published: December 13, 2018
Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis.
Journal: International journal of molecular sciences
Published: August 25, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026